Using ultrasound after birth to manage preeclampsia
Part of Blood & lymphatic, Cancer, Immune system & allergy, Women’s health & pregnancy clinical trials.
This study tests whether using a bedside ultrasound (POCUS) after childbirth can help doctors better manage women with preeclampsia. It looks at how well the heart and lungs are working to decide if a medicine called furosemide (a water pill) might help reduce blood pressure and prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You were diagnosed with preeclampsia (with or without severe features, HELLP syndrome, or eclampsia) during pregnancy or within 24 hours after delivery.
- You delivered your baby at 20 weeks or later in the pregnancy.
- You do not have a history of high blood pressure before pregnancy (chronic hypertension).
- You do not have kidney disease (stage 3 or higher) or current kidney problems (creatinine level above 1.1 mg/dL).
- You are not allergic to furosemide (a water pill) or sulfa drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses lung ultrasound to see if women with severe preeclampsia have too much fluid in their lungs, which could help guide treatment. It may help decide who needs closer monitoring or faster delivery.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This study looks at how biomarkers (specific substances in your blood) might help doctors better manage postpartum preeclampsia—high blood pressure and other symptoms that can appear after having a baby. You may qualify if you have severe preeclampsia during delivery or are receiving standard care after delivery.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
This study tests a new approach to prevent long-term heart and kidney problems in people who had preeclampsia, HELLP syndrome, or kidney disease during pregnancy. It aims to see if early follow-up care can improve future health.
This study looks at how the heart and blood vessels work after a pregnancy complicated by preeclampsia. It uses exercise testing to see if there are lasting effects, which may help improve long-term heart health monitoring and care.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.